Associations between Alzheimer's Disease (AD) and Obesity—Clinical Trials of NA-813 for AD and NA-931 for Obesity

Related

• Cell Metabolism·8 Oct 2026

  A triple-target drug cut body weight by up to 19.7% in a trial

  

• Journal of Neurochemistry·2 Oct 2026

  Pan-AMPK activator MK-8722 improves spatial memory in Alzheimer's model mice

  

• The New England Journal of Medicine·4 Oct 2026

  Survodutide reduces weight in adults with diabetes and obesity

  

• Neurology Genetics·4 Oct 2026

  GLP-1 receptor agonists link to lower stroke and Alzheimer risk